(S (NP (NP (JJ Adverse) (NN drug) (NN reaction)) (PRN (-LRB- -LRB-) (NP (NNP ADR)) (-RRB- -RRB-))) (VP (VBZ is) (VP (ADVP (RB widely)) (VBN concerned) (PP (IN for) (NP (JJ public) (NN health) (NN issue))))) (. .))
(S (NP (NNS ADRs)) (VP (VBP are) (NP (NP (CD one)) (PP (IN of) (NP (NP (ADJP (JJS most) (JJ common)) (NNS causes)) (SBAR (S (VP (TO to) (VP (VB withdraw) (NP (DT some) (NNS drugs)) (PP (IN from) (NP (NN market))))))))))) (. .))
(S (NP (NP (NNP Prescription) (NN event) (NN monitoring)) (PRN (-LRB- -LRB-) (NP (NNP PEM)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN approach)) (SBAR (S (VP (TO to) (VP (VB detect) (NP (DT the) (JJ adverse) (NN drug) (NNS reactions)))))))) (. .))
(S (NP (NP (DT The) (JJ main) (NN problem)) (SBAR (S (VP (TO to) (VP (VB deal) (PP (IN with) (NP (DT this) (NN method)))))))) (VP (VBZ is) (SBAR (WHADVP (WRB how)) (S (VP (TO to) (VP (ADVP (RB automatically)) (VB extract) (NP (DT the) (NX (NX (JJ medical) (NNS events)) (CC or) (NX (JJ side) (NNS effects)))) (PP (IN from) (NP (NP (JJ high-throughput) (JJ medical) (NNS events)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN collected) (PP (IN from) (NP (ADJP (NN day) (TO to) (NN day)) (JJ clinical) (NN practice)))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ novel) (NN concept)) (PP (IN of) (NP (NN feature) (NN matrix)))) (S (VP (TO to) (VP (VB detect) (NP (DT the) (NNP ADRs)))))) (. .))
(S (NP (NP (NN Feature) (NN matrix)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN extracted) (PP (IN from) (NP (NP (JJ big) (JJ medical) (NNS data)) (PP (IN from) (NP (DT The) (NNP Health) (NNP Improvement) (NNP Network) (PRN (-LRB- -LRB-) (NNP THIN) (-RRB- -RRB-)) (NN database))))))))) (, ,)) (VP (VBZ is) (VP (VBN created) (S (VP (TO to) (VP (VB characterize) (NP (NP (DT the) (JJ medical) (NNS events)) (PP (IN for) (NP (NP (DT the) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP take) (NP (NNS drugs))))))))))))) (. .))
(S (NP (NN Feature) (NN matrix)) (VP (VBZ builds) (NP (NP (DT the) (NN foundation)) (PP (IN for) (NP (DT the) (ADJP (NN irregular) (CC and) (JJ big)) (JJ medical) (NNS data))))) (. .))
(S (ADVP (RB Then)) (NP (NN feature) (NN selection) (NNS methods)) (VP (VBP are) (VP (VBN performed) (PP (IN on) (NP (NN feature) (NN matrix))) (S (VP (TO to) (VP (VB detect) (NP (DT the) (JJ significant) (NNS features))))))) (. .))
(S (ADVP (RB Finally)) (NP (DT the) (NNP ADRs)) (VP (MD can) (VP (VB be) (VP (VBN located) (S (VP (VBN based) (PP (IN on) (NP (DT the) (JJ significant) (NNS features)))))))) (. .))
(S (NP (DT The) (NNS experiments)) (VP (VBP are) (VP (VBN carried) (PRT (RP out)) (PP (IN on) (NP (NP (CD three) (NNS drugs)) (: :) (NP (NP (NNP Atorvastatin)) (, ,) (NP (NNP Alendronate)) (, ,) (CC and) (NP (NNP Metoclopramide))))))) (. .))
(S (S (NP (NP (JJ Major) (NN side) (NNS effects)) (PP (IN for) (NP (DT each) (NN drug)))) (VP (VBP are) (VP (VBN detected)))) (CC and) (S (NP (JJR better) (NN performance)) (VP (VBZ is) (VP (VBN achieved) (PP (VBN compared) (PP (TO to) (NP (JJ other) (JJ computerized) (NNS methods))))))) (. .))
(S (S (NP (DT The) (JJ detected) (NNP ADRs)) (VP (VBP are) (VP (VBN based) (PP (IN on) (NP (JJ computerized) (NNS methods)))))) (, ,) (S (NP (JJ further) (NN investigation)) (VP (VBZ is) (VP (VBN needed)))) (. .))
